Longtime Seattle Genetics COO Jumps Ship to Helm Biotech Startup Silverback Therapeutics Post author:Sam Post published:December 3, 2017 Post category:BioPharma The COO of Seattle Genetics, Eric Dobmeier, is leaving the company to helm Silverback Therapeutics. Source: BioSpace You Might Also Like AIT Therapeutics Raises Gross Proceeds Of $10.9 Million And Completes Reverse Merger April 4, 2017 Aldeyra Therapeutics Inks Collaboration Deal with Johnson & Johnson to Develop Anti-inflammatory … February 26, 2018 3 Biotechs Predicted to Grow 415% and More in 2018 May 3, 2017
Aldeyra Therapeutics Inks Collaboration Deal with Johnson & Johnson to Develop Anti-inflammatory … February 26, 2018